AstraZeneca and Ionis Pharmaceuticals have finalized their agreement to develop and commercialize investigational therapy eplontersen, formerly known as Ionis-TTR-L. The...
10.09.2019
- GlaxoSmithKline (GSK) has exercised its option to license an investigational treatment from Ionis Pharmaceuticals for chronic hepatitis B infection (CHB). The major UK drugmaker is...
